Evaluation of NK1 antagonists for emesis prevention in oxaliplatin chemo: SENRI trial
Wednesday, July 1, 2015 - 09:30
in Health & Medicine
The SENRI trial has opened the window to evaluate NK1 antagonists for emesis prevention in patients taking oxaliplatin chemotherapy, results of a new study.